Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme - Wikidata - awgldk - TriplyDB

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

http://www.wikidata.org/entity/Q24682970

about

Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition Determinants of the inhibition of a Taiwan habu venom metalloproteinase by its endogenous inhibitors revealed by X-ray crystallography and synthetic inhibitor analogues NMR structure of the netrin-like domain (NTR) of human type I procollagen C-proteinase enhancer defines structural consensus of NTR domains and assesses potential proteinase inhibitory activity and ligand binding Structural basis for autoinhibition of Notch Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL Amidation of Bioactive Peptides: The Structure of the Lyase Domain of the Amidating Enzyme Structural basis for the sheddase function of human meprin metalloproteinase at the plasma membrane A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Catalytic activity of human ADAM33 The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3 The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE)Extracellular phosphorylation of collagen XVII by ecto-casein kinase 2 inhibits ectodomain shedding Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4 The canonical Notch signaling pathway: unfolding the activation mechanism.Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region Molecular analysis of ulilysin, the structural prototype of a new family of metzincin metalloproteases.Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10 Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.Hepatoprotective activity of chrysin is mediated through TNF-α in chemically-induced acute liver damage: An in vivo study and molecular modeling.ADAM-17: the enzyme that does it all.ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.Tumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseases Positive evolutionary selection of an HD motif on Alzheimer precursor protein orthologues suggests a functional role.Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold Metalloproteinases: their role in arthritis and potential as therapeutic targets.Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation.

P2860

Q24534110-7F8C6DDA-F067-44A9-9971-B3AB649B41AE Q24685839-2BE3AC8A-7F5F-40BE-80F8-A85E042C02DD Q26747656-1B97D1C2-46F8-4BAD-8FB6-1C71C6DB26E0 Q26749364-5B4122ED-DBD4-4B8F-8C2A-F7171EF1C866 Q27329590-BD4EA79D-1AD2-4FD4-84AE-49DCF74804AD Q27630877-EDD66317-E4C1-433C-B948-5821DBDB547A Q27639192-0BB527FD-6FB5-4226-8FF9-3EDFDDE59D7D Q27640875-7A2489AC-B767-4CC3-829D-AEB772821C83 Q27644319-F34A6783-7050-4AAF-9951-9E85BEA3796F Q27644715-750AD387-4E40-4B09-8FA9-84690459E441 Q27648987-8C3358AC-9C78-4AFF-AFDE-6246E939124D Q27653136-81AFCD29-A713-4394-8609-7F9523E06CF3 Q27656445-766E33F9-A768-4653-8FD6-5D4380B0846F Q27673367-B3E411B2-C4E8-414B-9EB6-AF19159FFE90 Q28072451-08153C36-AAC9-4E2D-8E0D-2466AE5878E9 Q28137781-DA6BA703-E36A-462D-A88D-76F809BAD0E1 Q28140038-A6F68733-CE38-4263-82F6-605F94F913D2 Q28191609-3E83EEF7-6744-49A9-9441-9EC18A8E2B1C Q28202274-77EC8FE2-C571-4F87-B05C-2E6F7C898079 Q28205859-B80F7A79-6358-4FB6-82F2-16A48F7A358D Q28304833-ABB2D496-6DB3-45AD-B168-83D3ED21EC43 Q28609073-F2123252-FACF-45D6-BBE3-89F26373C330 Q29547725-EA0F1103-0FF7-4B98-AF33-3931ACBAD761 Q30352829-EE52C79D-C8C3-4F6F-8E31-38C929045306 Q30525783-5910B67D-774B-4BC0-8063-5978B2734B5C Q33240511-694521D9-0D82-434E-8601-C964D917D068 Q33498106-C1D1AE30-C033-49C0-B349-FBDFBF18EDD9 Q33599723-14542139-CB2A-417C-AB55-D81436680113 Q33692956-8A4F0215-EA21-42A4-9CA0-45AD1CC1792F Q33715032-38EF1A2B-7B04-4E1B-A856-177911E5F560 Q33724192-E77487E7-70F0-4563-85CE-CB0FD4D9229C Q33737421-9845718F-5FBE-4FB2-A78E-1D7DBF1DC1EF Q33805782-B69A4718-99B5-48F4-97E4-D24697A9D4A6 Q33891912-1CBCA32B-F6D1-4A87-A379-138D39A618F7 Q34154430-00A3D7C6-D7B2-42B8-B815-4913518FB179 Q34410435-A86ABC29-2FE4-4D34-BB81-B5F574279A21 Q34513677-AD058D96-5FFB-46EB-B7EF-4488AFEBF124 Q34676632-3DBABF54-634D-477A-8B5E-3E5C6D074A06 Q35056019-22EC7A00-30DB-47B7-AE79-0F005D70E407 Q35604229-40E988D6-2D05-49AB-BC15-A468D75C8981

P2860

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

http://www.wikidata.org/entity/Q24682970

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Crystal structure of the catal ...... factor-alpha-converting enzyme

@ast

Crystal structure of the catal ...... factor-alpha-converting enzyme

@en

Crystal structure of the catal ...... factor-alpha-converting enzyme

@nl

type

label

Crystal structure of the catal ...... factor-alpha-converting enzyme

@ast

Crystal structure of the catal ...... factor-alpha-converting enzyme

@en

Crystal structure of the catal ...... factor-alpha-converting enzyme

@nl

prefLabel

Crystal structure of the catal ...... factor-alpha-converting enzyme

@ast

Crystal structure of the catal ...... factor-alpha-converting enzyme

@en

Crystal structure of the catal ...... factor-alpha-converting enzyme

@nl

P1433

Q24682970-8D4ED730-533A-43FB-97DC-A13222770A86

P1476

Q24682970-E1EF161A-9145-485E-ACA9-A023D7056856

P2093

Q24682970-1C9DE3B5-10AF-4076-A4D9-81FE6A92605E

Q24682970-23391A20-A3B0-4187-A4B0-15800CB09A04

Q24682970-252CAFE1-9703-45A9-94A9-B7A0B07846DB

Q24682970-2FC039DE-7F81-4D15-993E-7CD416306E62

Q24682970-3069A41E-0ACF-4087-95FF-BDE282B72F79

Q24682970-42B733A7-0715-4B39-B39C-0AB8E8F58B57

Q24682970-4AB16B97-8452-4D7E-AF5B-2E07592381FE

Q24682970-5236F3B0-2CAC-43AF-B3FA-864D2C122DBF

Q24682970-54A3067E-B25B-4FEF-8CBE-8714280D1B4F

Q24682970-5B2E2762-A313-4965-AB9E-DF1AA9DDD129

P2860

Q24682970-0610C154-D294-451A-950E-9F027EAEC665

Q24682970-116392A1-03A0-441E-A1FF-B985C486D0F1

Q24682970-262DAA14-0F99-48F9-83C7-09BE0836D159

Q24682970-357092EA-ED35-406D-9F18-9E98CCD60140

Q24682970-375CA4AF-D5EC-487A-B4DC-C646C39F360C

Q24682970-4B4C7BDC-263A-4B9D-80F5-A2D334BA4BC3

Q24682970-57713CB4-2594-4A74-AE15-29417D382173

Q24682970-5ABB812E-2C35-4174-9E24-D4EEA05A0024

Q24682970-6860E0E2-8C84-4CA2-A57D-63316D9F359B

Q24682970-6C83EFA6-D23F-425F-BC4D-2035100ECD7F

P304

Q24682970-E32F9C94-080C-4FE0-ABE2-CE8020E0BC2B

P31

Q24682970-212F210C-E67D-4AD7-9CF2-699434C1F11C

P3181

Q24682970-70F581C1-BB39-4C5A-AEBC-F8191F4BBE34

P356

Q24682970-D7CC3CC7-A5EB-4FF1-AC1C-0DB2CE2969D5

P407

Q24682970-7483F60B-577A-40CA-8146-A320F8433390

P433

Q24682970-0569164B-187E-4B1D-AA0F-3BF894298742

P478

Q24682970-917E95F6-21C8-4D53-A51C-98DC31B54036

P577

Q24682970-FE72126C-439A-494D-A5FF-99599B63A3C4

P5875

Q24682970-A9CAC690-90E3-4B2A-A0C9-14207F0FFF96

P698

Q24682970-AA75A05A-8A8E-443A-85EE-DC4F58FD48B2

P921

Q24682970-CC5DE11C-04E4-4C47-BDC3-E1A7C868B3C7

P932

Q24682970-91CEA8BC-50F9-4A8D-9BFC-DCBE2198BDB2

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Crystal structure of the catal ...... factor-alpha-converting enzyme

@en

P2093

B J Castner

http://www.w3.org/2001/XMLSchema#string

C Fernandez-Catalan

http://www.w3.org/2001/XMLSchema#string

C J March

http://www.w3.org/2001/XMLSchema#string

C T Rauch

http://www.w3.org/2001/XMLSchema#string

D P Cerretti

http://www.w3.org/2001/XMLSchema#string

G A Ellestad

http://www.w3.org/2001/XMLSchema#string

G P Bourenkov

http://www.w3.org/2001/XMLSchema#string

H Bartunik

http://www.w3.org/2001/XMLSchema#string

H R Clarke

http://www.w3.org/2001/XMLSchema#string

J N Fitzner

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases

X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design

Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d)

First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases

Crystal structure of H2-proteinase from the venom of Trimeresurus flavoviridis

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

SETOR: hardware-lighted three-dimensional solid model representations of macromolecules

The CCP4 suite: programs for protein crystallography

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

P304

3408-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1584414

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.95.7.3408

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51314436

http://www.w3.org/2001/XMLSchema#string

P698

9520379

http://www.w3.org/2001/XMLSchema#string

P921

crystal structure

P932

19849

http://www.w3.org/2001/XMLSchema#string